ADVERTISEMENT

Dishman Carbogen Amcis Q1 Review - Strong Growth In Marketable Molecules; CRAMS Business Flattish: Nirmal Bang

Dishman Carbogen Amcis Q1 Review - Strong Growth In Marketable Molecules; CRAMS Business Flattish: Nirmal Bang

<div class="paragraphs"><p>Tablets of the hyperactivity drug arranged for photograph.&nbsp; &nbsp;(Photographer: JB Reed/Bloomberg News )&nbsp;</p></div>
Tablets of the hyperactivity drug arranged for photograph.   (Photographer: JB Reed/Bloomberg News ) 
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More